Genmab — Maj 2019
-
God morgen.

-
-
Bliver spændende at se data fra Genmabs CD20/CD3 antistof - og lad os så få en stor partner på programmet, så der kan komme far t over feltet. Hvis Regeneron allerede forventer at starte pivotale studier i DLBCL og FL i år. Roche er lige i hælene og dem ved vi, at man ikke skal give for lang en snor.
-
Var det noget med recepttal i dag?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind